Cureglim MP 1mg/500mg/15mg Tablet ER
By Cureglim MP
Rx
10 Tablet ER in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Pioglitazone(15mg)

Manufacturer - Curega Healthcare Pvt Ltd
Office No -4, C/2 Building, Simplicity, Handewadi Road , Hadapsar, Pune - 412308 Maharashtra, India

Expires on or after
August, 2025

liver
When using Cureglim MP 1mg/500mg/15mg Tablet ER, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Cureglim MP 1mg/500mg/15mg Tablet ER, so it's best to consult your doctor before use. However, individuals with severe liver disease are advised not to use Cureglim MP 1mg/500mg/15mg Tablet ER. It's crucial to follow your healthcare provider's guidance closely for your safety.

kidney
Cureglim MP 1mg/500mg/15mg Tablet ER should be used carefully in patients with kidney issues. Adjusting the dose may be necessary. Refrain from using it in severe kidney problems. Monitor kidney function regularly when on this medication.

alcohol
Do not drink alcohol while taking Cureglim MP 1mg/500mg/15mg Tablet ER.

driving
When taking Cureglim MP 1mg/500mg/15mg Tablet ER, be cautious when driving. If you experience low or high blood sugar symptoms, refrain from driving as it could affect your ability to focus and react effectively.

pregnancy
Cureglim MP 1mg/500mg/15mg Tablet ER could be harmful during pregnancy due to limited human studies and observed risks in animal studies. Consult your doctor for guidance as they will assess the benefits and potential risks before prescribing this medication to you.

breastfeeding
Caution Cureglim MP 1mg/500mg/15mg Tablet ER is likely unsafe while breastfeeding. Limited data indicates the drug can pass into breastmilk and potentially harm the infant.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹90
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024